• Utilize high throughput screening approaches to identify potential improvements to platform purification processes
• Leverage manufacturing process data to avoid unacceptable process variability and implement process improvements when needed
• Apply the latest analytical tools to optimize the development of robust manufacturing processes
• Review data from an extensive evaluation of a completely new method for antibody purification applications which could have a profound effect on monoclonal antibody platforms
• Integrate new technologies and approaches to accommodate large-scale multi-product clinical manufacturing

View the agenda:

• Thurdsay
• Friday